10th Annual Pharma Anti-Counterfeiting & Serialisation 2022
Share
Now
WHY SHOULD YOU ATTEND?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Event Speakers
RORY CORCORAN
INTERPOL’s Financial Crime and Anti-Corruption Centre
RORY CORCORAN
INTERPOL’s Financial Crime and Anti-Corruption Centre
RORY CORCORAN, Director, Pro Tempore, INTERPOL’s Financial Crime and Anti-Corruption Centre
A seconded Detective Inspector from the Irish Police (An Garda Sìochàna), Rory joined INTERPOL in 2018 wherehe currently holds the position of Acting Assistant Director in the Illicit Markets Sub Directorate. He has responsibility for overseeinga number of INTERPOL’s Organized Crimes programmes including, Environmental Security (ENS) andIllicit Goods and Global Health (IGGH).
He has 30 years’ experience in Law Enforcement having served the majority of his career in the Garda Counter Terrorism Unit and most recently in the Garda National Economic Crime Bureau. He hold a Master’s and Post Graduate Degree in Legal Studies and also holds academic qualifications in Cyber Crime, Financial Crime Investigations and Corporate Risk and Governance, from University College Dublin, Ireland.
THOMAS A. D
Homeland Security Investigations
THOMAS A. D
Homeland Security Investigations
THOMAS A. DUFFY, Section Chief-IPU - IPR Center, Homeland Security Investigations
JYRKI SYVAERI
Boehringer Ingelheim
JYRKI SYVAERI
Boehringer Ingelheim
JYRKI SYVAERI, Corporate Director Supply Chain Integrity, Boehringer Ingelheim
Jyrki Syväri, Pharmacist and Chemist, made his PhD Theses in Pharmaceutical Chemistry and his Diploma in Chemistry in Analytical Chemistry. He joined Schering AG in Berlin and headed there a R&D Laboratory for the development of parenteral drugs. After leaving Schering he joined Boehringer Ingelheim to become a Project Manager in Operations. He was responsible for the world-wide launches of new products, such as Metalyse and Spiriva. Thereafter he was heading a group called “Launch and Special Supplies”. In this function he was responsible for setting up supply chains for Boehringer Ingelheim’s new products. New Supply Chain paradigms and concepts fell also under his responsibility. In this context he became the world-wide program leader for BI’s Product Safety & Security project that centers around serialization, track & trace. Additionally, Jyrki is leading the global initiative Supply Chain Integrity which takes a broader view on supply chain security, transparency and Risk Management.
STEFAN ARTLICH
Bayer
STEFAN ARTLICH
Bayer
STEFAN ARTLICH, Director ‘Track&Trace’, Bayer
Being a mathematician and chemical engineer by profession Stefan is involved in pharmaceutical serialization since its early days in 2008 and renowned as one of the fathers of the European ‘Point-of-Dispense Verification’ model that ensures patients’ access to safe medicines.
For more than seven years Stefan worked as a delegate consultant for the European Federation of Pharmaceutical Industries and Associations (EFPIA) where he contributed to the successful verification pilot in Sweden in 2009 / 2010 and played a key role in the design and development of the European Medicines Verification System (EMVS) that constitutes a key component in the implementation of the EU Falsified Medicines Directive (FMD).
Once having returned from Brussels Stefan led Bayer’s activities to implement the Brazilian Track&Trace requirements in 2014 and 2015 before his focus shifted back to the roots as the responsible program manager for the timely FMD readiness of Bayer’s Pharmaceuticals and Consumer Health divisions by February 2019.Currently, he manages Bayer’srollout of Track&Trace for Brazil that was restarted by ANVISA in 2020 and to introduce the non-serialized 2D coding on the secondary packaging for Canada.
NEIL LAWRENCE
GSK
NEIL LAWRENCE
GSK
NEIL LAWRENCE, Global Serialisation Champion, GSK
“Neil Lawrence joined GSK in March 2013 to work as a governmental and regulatory expert on the global Serialisation programme. Neil previously worked at the department of health and Cabinet office as a patient safety expert for the English Health Service. A long term advocate of Patient Safety above all Neil continues to ensure that GSK’s approach to Serialisation and coding is patient centric and focused on securing the supply chain.”
ALEXANDRU P
MSD
SEBASTIEN M
Ferring Pharmaceuticals
SEBASTIEN M
Ferring Pharmaceuticals
SEBASTIEN MAUEL, Head of Serialization and Product Security, Ferring Pharmaceuticals
Sebastien Mauel is Head of Serialisation and Product Security at Ferring Pharmaceuticals. He is notably responsible for Ferring’s global Serialisation Project, whose goal is to make the Ferring manufacturing sites compliant with the various serialisation regulations worldwide and to build the corresponding IT infrastructure that will centrally manage all of the serialisation data.
Prior to that role, Sebastien served in various Manufacturing, Supply Chain and Product Security positions at Serono and Merck KGaA in Switzerland and Germany. Sebastien holds a Master in Chemical Engineering from the Swiss Federal Institute of Technology, and the CPIM and CSCP certifications from APICS.
HEIKO TREFZGER
Roche
HEIKO TREFZGER
Roche
HEIKO TREFZGER, Product Manager, Business Analyst, Innovation, Representative, Roche
Heiko Trefzger, born in 1975, studied business administration with a focus on business informatics. He has almost 25 years of experience in business-IT interfacing functions in chemical and pharmaceutical industries. He is a proven expert in methods and processes in business analysis and solution management. For more than 16 years he has been working at F. Hofmann-La Roche as a business data processing specialist and business solution manager and has managed numerous strategic and business-critical projects in a global environment. As a product manager for artworks and anti-counterfeiting, he has acquired extensive know-how within the supply chain and manufacturing. He has received several awards for his activities and projects, including a “CIO Award”, the “Business Process Excellence Award” and, ultimately, for “Distinguished Team Performance” as part of an in-house innovation competition. From 2013 to 2016 he also headed a global Business Solution Manager Forum with over 80 members, successfully introducing standards for methods and processes for business analysis and portfolio management. Heiko Trefzger also lectures at the Cooperative State University in Lörrach.
BHARAT B R
Mankind Pharma
CLAIRE CLARKE
GS1
CLAIRE CLARKE
GS1
CLAIRE CLARKE, Director Healthcare Engagement, GS1
Claire Clarke is Director of Healthcare Engagement at GS1. Claire’s passion is to ensure that patients receive the best healthcare possible. Healthcare systems need support to eliminate errors and using global standards can help in achieving this. Claire is a senior nurse leader with over 25 years experience within the healthcare system, leading teams within complex organisations. Within these organisation Claire has led transformational business change that has delivered excellent business performance along with outstanding care delivery. Claire prides herself on enabling an open environment to enable teams to drive innovation, accountability and professional integrity whilst enjoying the job
EIKE STRUTZ
Boehringer Ingelheim
EIKE STRUTZ
Boehringer Ingelheim
EIKE STRUTZ, Corporate Security Manager, Boehringer Ingelheim
Since 01/2019: Corporate Security Manager, Boehringer Ingelheim Know-how Protection and Travel and Expat Security
05/2016 – 12/2018: Head of Security, DB Schenker Germany Supply Chain Security, Protection of classified information, Airfreight security and sanction lists.
07/2015 – 04/2016: Corporate Security Manager, Canyon Bicycles Site Security, Payment fraud
07/2012 – 06/2015: Open Source Intelligence Analyst, Freelancer Open source research, Risk assessments
10/2010 – 06/2012: Security Manager; Merck KGaA Site security, Event security, Travel security, Anti-counterfeit
09/2001 – 08/2005: German Armed Military Police and Close Protection Officer
KIRAN KULKARNI
Aurobindo Pharma
KIRAN KULKARNI
Aurobindo Pharma
KIRAN KULKARNI, Senior Manager Packaging Development, Aurobindo Pharma
Leading team of nine members, independently monitoring successfully Packaging Development activities of US Market and Projects. Handling New Launches, Submission and Post commercial changes of all formulation units. Actively handling various projects related to Cost Improvement, Productivity Improvement and Process Simplification.
Successfully Implemented Drug Supply Chain Security Act for all the SKUs of US market across all the Formulation units of APL. Evaluation of Artworks, Revisions, Machine Trials, Training, Co ordination with SCM Planning and implementation through Change Controls
SHIVAJI C
Fresenius Kabi
SHIVAJI C
Fresenius Kabi
SHIVAJI CHAKRABORTY, Asst. General Manager, Fresenius Kabi
Packaging professional with more than 25 years of experience in packaging designing, development and commercialization, vendor development, project management and execution.
Skilled in process improvement with a focus on cost impact, process improvement and sustainability.
Presently associated with Fresenius Kabi Oncology Ltd for more than a decade. Heading Packaging development functions, e.g., packaging development and commercialisation of pharmaceutical formulations, projects, productivity initiatives, vendor development, process improvement, leadership, and mentoring.
GAURAV BHATIA
Reliance Retail-Pharma
GAURAV BHATIA
Reliance Retail-Pharma
GAURAV BHATIA, General Manager - Supply Chain, Reliance Retail-Pharma
SULTAN DAJANI
Wainwrights Chemists
SULTAN DAJANI
Wainwrights Chemists
SULTAN DAJANI, Pharmacist Superintendent, Wainwrights Chemists
Sultan ‘SID’ Dajani qualified in 1994 and was elected onto the Council of The Royal Pharmaceutical Society of Great Britain (RPS) in 1997 as the youngest member in its 175-year history. He has had over 400 articles published, is a national and international presenter and consultant and has had over 300 TV and radio appearances as well as trade and national press coverage.He has is an adviser as well as appearing on the TV show ‘Save Money;Good Health’ and in 2014 Womans Own magazine voted SID as Britain’s ‘Best Pharmacist’.
He has served on national and international committees as well as government working groups, on initiatives including the Public Health Leadership Forum, antimicrobial resistance and the legalisation of cannabis for medical purposes
MIKE ISLES
European Alliance for Access to Safe Medicines
MIKE ISLES
European Alliance for Access to Safe Medicines
MIKE ISLES, Executive Director, European Alliance for Access to Safe Medicines
Mike is the Executive Director for the Alliance for Safe Online Pharmacy in the EU (www.asop.eu), a non-profit Community Interest Company (CIC). With over 35,000 fake pharmacy websites targeting Europe on any given day, this multi sectoral organisation’s mission is to enable patients to buy their medicines online safely – where it is legal to do so. ASOP EU collaborates strongly with ASOP Global (www.buysaferx.pharmacy) and its members and observers involve many key internet stakeholders. Its aim is to facilitate and campaign for new legislation as well as concrete voluntary actions that will make a real difference and ultimately benefit the health and safety of patients.
KASPER ERNEST
Affordable Medicines Europe
KASPER ERNEST
Affordable Medicines Europe
KASPER ERNEST, Secretary Generalm, Affordable Medicines Europe
Kasper Ernest has worked for the last 11 years in European affairs in Brussels. Since 2018, he has been the Secretary-General of Affordable Medicines Europe. From 2009-2018 he was with the Confederation of Danish Enterprise, since 2015 serving as Director of the EU & International Department. He has also served as the Board Member of several EU-level business organisations, as a Member of the Danish Government’s Implementation Council, and was co-founder of the European Business Services Alliance. He holds a master’s degree in International Business and Politics from Copenhagen Business School and Singapore Management University. He is a guest lecturer at Copenhagen Business School.
GRANT C
Smarter and Safer Products
GRANT C
Smarter and Safer Products
GRANT COURTNEY, Founder and CEO, Smarter and Safer Products
Grant is the founder of Smarter and Safer Products, a Niche consulting company focused on making products both smarter and safer through digital enablement.
Clients include brand owners, solution providers, NGOs and other consultancies.
Prior to this he spent 24 years working in the Healthcare Industry for GlaxoSmithKline in both manufacturing, supply chain and commercial positions.
GUSTAVO MORAIS
Dannemann Siemsen
GUSTAVO MORAIS
Dannemann Siemsen
GUSTAVO MORAIS, Partner - Member of Managing Committee, Dannemann Siemsen
JOSE H. WERNER
Dannemann Siemsen
“Competences to Combat Counterfeits”
Event Schedule
Meet and to network with your conference colleagues.
09:30 – Welcome Address & Virtual Conference Platform Instructions
MARKET ANALYSIS & CURRENT OVIERVIEW
09:40 – FDA OCI enforcement initiatives during COVID-19
LUIS PEREZ, Attache, FDA OCI
SERIALISATION – TRACK & TRACE
10:20 – Serialisation in the Pharma – Points to remember
• Tackling Counterfeit Medicines
• The Serialisation Solution
• To consider – Right partner, Automation, Data Management & Exchange
• Key for successful serialization of pharmaceuticals: data is the cornerstone
• Alert Management – learnings from the EU
• Adapting to the changing regulatory environment
JYRKI SYVAERI, Corporate Director Supply Chain Integrity, Boehringer Ingelheim
11:00 – Morning Tea/Coffee
CHALLENGES & OPPORTUNITIES
11:20 – Keynote Panel Discussion :– Challenges and Opportunities - Waging war against counterfeit medicines
• Most common ways where drugs are counterfeited – Where should a company’s focus point be regarding this? How to handle it?
• Solutions based on the facts where consumers fall as victims to counterfeiters
• Fightback Against Counterfeit Online Medicine Suppliers
• Next-generation anti-counterfeiting – How to prepare for it? What should be done?
• Market analysis and what to learn from other countries?
• Utilize social media and educate the consumer to identify counterfeit drugs
• Take advantage of new technologies
Moderator
GRANT COURTNEY, Founder and CEO, Smarter and Safer Products
Panelists
EIKE STRUTZ, Corporate Security Manager, Boehringer Ingelheim
KASPER ERNEST, Secretary General, Affordable Medicines Europe
KIRAN KULKARNI, Senior Manager Packaging Development, Aurobindo Pharma
SHIVAJI CHAKRABORTY, Asst. General Manager, Fresenius Kabi
12:10 – Delivering Smarter Medicines
On-dose authentication technology can help deter counterfeiters, while also helping patients better engage with their medicines. SoteriaRx® provides a level of authenticity, transparency, and brand protection not previously available to the Pharma industry. Incorporating taggants directly into a product’s film coating or pri¬mary packaging provides a unique opportunity for brands to secure their product with real-time verification. Using a smartphone app extends this technology to enable faster decision making and provides a unique way to interact with patients to improve outcomes. Through real-time data collection and analysis, patient-focused product teams can make medicines smarter and provide more personalized support resources as needed.
• Protect company reputation and brand integrity
• Secure product and improve patient safety
• Smart medicines to connect with your patients
GARY POND, Global Program Manager – Authentication, Colorcon
12:40 – Networking luncheon
13:30 - A safe and secure supply chain – realising the patient safety benefits
• Why GS1 standards are being mandated by regulators
• Safe & secure supply chain, its benefits
• Realising and enabling the patient safety benefits.
CLAIRE CLARKE, Director Healthcare Engagement, GS1
INTELLECTUAL PROPERTY PROTECTION
14:10 – Homeland Security Investigations Presents - Pharmaceutical and Medical Device Overview
• HSI 101
• Pharma and health products overview
• Op Stolen Promise (CV-19) overview
ALBERT CABRELLI, Assistant Attaché, Homeland Security Investigations
THOMAS A. DUFFY, Section Chief-IPU - IPR Center, Homeland Security Investigations
14:50 – The experiences of the European Medicines Verification System and the current challenges.
KASPER ERNEST, Secretary General, Affordable Medicines Europe
15:20 – Afternoon Tea/coffee
FIGHTING FAKES – BRAND PROTECTION
15:40 - Counteracting Counterfeits in Medicines
• Why this is a serious public health issue
• Ways to spot fakes
• Solutions to this growing problem
SULTAN DAJANI, Pharmacist Superintendent, Wainwrights Chemists
16:20 - Improvement of anti-counterfeiting measures during the Pharma Industry 4.0 transformation
• Mindset change – from 2.0 to 4.0
• Industry 4.0 will improve protection of the pharmaceutical goods
• What about the multiple serialization initiatives
PATRIK MERCKELL, CEO, Disruptor and Founder, accent.world sa
16:50 - End of Day One Conference
09:40 – A multisector approach to tackling counterfeiting and piracy during the pandemic
• Information sharing between Public & Private Sectors during the pandemic
• INTERPOL’s Operation PANGEA 2022
• INTERPOL’s tactical response to counterfeit vaccines/ medicines
• The way forward
RORY CORCORAN, Director, Pro Tempore, INTERPOL’s Financial Crime and, Anti-Corruption Centre
SERIALISATION – TRACK & TRACE
10:20 – Serialisation by demand and by design
• How the legal requirement for Serialisation and Traceability has been met
• The opportunities this has created within supply chain
• How EPL and Blockchain will provide greater benefits
NEIL LAWRENCE, Global Serialisation Champion, GSK
11:20 – Panel Discussion with the experts– Serialisation: The Next Frontier for Packaging Security and Traceability
• Securing your supply chain
• Gaining value from Serialization: Efficient internal operations
• Practical approach to implementing a serialisation solution – Challenges and Solutions
• Track & Trace – The smart solution
• What are the traceability challenges still to overcome in the next 5 years?
• Viewing serialisation as an opportunity – Business and Supply chain optimisation
Moderator
GRANT COURTNEY, Founder and CEO, Smarter and Safer Products
Panelists
NEIL LAWRENCE, Global Serialisation Champion, GSK
SEBASTIEN MAUEL, Head of Serialization and Product Security, Ferring Pharmaceuticals
HEIKO TREFZGER, Product Manager, Business Analyst, Innovation, Representative, Roche
BHARAT BHUSHAN RATHI, Head Logistics, Mankind Pharma
GAURAV BHATIA, General Manager - Supply Chain, Reliance Retail-Pharma
11:00 – Morning Tea/Coffee
12:10 – Are the GS1DataMatrix Code’s Days Already Numbered?
• Role of 2D GS1 DataMatrix and EAN/UPC linear barcodes today
• Why we see the use of QR codes increasing as well in the healthcare sector
• How the GS1 Digital Link standard comes into play
STEFAN ARTLICH, Director ‘Track&Trace’, Bayer
12:40 – Networking luncheon
13:40 – Prevention Initiative Against Product Crime in hot-spot countries
Besides robust anti-counterfeiting features applied to pharmaceuticals, preventative actions and raising the awareness on the danger of product crime in hot-spot countries by fostering relationships within the company as well as with external stakeholders, are key to protecting patients
HUGUES ISEL, Global Quality Issue Manager, Roche
COMBATING FAKE DRUGS ONLINE
14:20 – Solutions to combat the rising tide of online falsified medicines
• There is no one silver bullet to eradicate falsified medicines from the Internet
• Many new legislative and best practice initiatives are providing concrete solutions
• Top level verified domain names such as the .pharmacy National Association of Boards of Pharmacy is adding greatly to patient safety
• The presentation will describe other practical solutions to combat falsified medicines online
MIKE ISLES, Executive Director, European Alliance for Access to Safe Medicines
15:00 – Afternoon Tea/coffee
15:20 - How MSD is fighting counterfeit drugs with blockchain technology
Global Pharma supply chains are increasingly complex, with products passing through multiple entities in their journey to the patient. The level of counterfeited material entering the market has increased over time, also as it has become more complex to detect counterfeited products. As a result, patient safety is put at risk and it’s creating loss of public confidence in pharmaceutical products. As part of the fight against counterfeiting, health authorities around the world are publishing legislation forcing pharma companies to serialize products at the unit level to enable traceability of the product from the manufacturing site until the patient. Learn how MSD is addressing these challenges in fighting counterfeited medicine with blockchain technology
ALEXANDRU POPA, Associate Director, Blockchain for Pharma Supply Chain, MSD
REGULATORY
16:00 – PHARMA REGULATORY ASPECTS IN BRAZIL
• Overview
• Recent Discussions
• National Legislation
• Compulsory Licenses?
GUSTAVO MORAIS, Partner - Member of Managing Committee, Dannemann Siemsen
PHARMA & BORDER PROTECTION IN BRAZIL
• How make it possible?
• Why this should be part of your market protection?
• Advantages
• Practical Cases
JOSE H. WERNER, Partner, Dannemann Siemsen
17:00 – End of conference
Share
Now
Event Sponsors & Partners
Colorcon
Colorcon is a world leader in the development, supply and support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our purpose is to improve health and wellness through convenience, compliance and safety. Our best-in-class products and technologies are complemented by our extensive application data and value-added services to support all phases of solid oral dose design, development, and manufacture.
Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations. Colorcon has 11 manufacturing facilities including 7 film coating plants, 22 technical service laboratories globally and more than 1300 employees exclusively dedicated to its customer base.
Virtue Insight
CONCEPTUALISED BY
Virtue Insight
CONCEPTUALISED BY
Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.
Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.
Testimonials
WCO IPM Manager
Food And Drugs Authority, Ghana Head, Market Surveillance Unit
Element Six Business Development Manager
Bayer Consumer Care AG Head Global Packaging Management
horus security Horus Security Consultancy
Presentations
Get Involved
Speaking Opportunities
Fen Castro
fen@virtueinsight.co.in
+91 44 42108101
Sponsor / Exhibit / Delegate Bookings
Piyush Patel
piyush@virtueinsightevents.com
+44 20 3509 3779
